In this article, João Pereira, Team Leader R&D Analytical Development, and Raquel Borda D’Água, Associated Analytical Chemist, both at Hovione, and Mark Copley, Chief Executive Officer, and Anna Sipitanou, Business Development Manager, both at Copley Scientific, discuss the semi-automation of cascade impactor testing and the benefits it can bring in terms of quality of orally inhaled products test data, and reductions in cost and effort associated with routine, critical measurements.
This article was taken from ONdrugDelivery November 2020. © 2024 Frederick Furness Publishing.
